About: Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Latest price: $13.55 (+0.82%)
STVN NYSE Stevanato Group SpA
Stevanato Group SpA share price
STVN price activity
Last Price
$13.550
Change (24hr)
0.11 USD (0.82%)
Volume
1.03M
Volume (4w avg)
-
Open
$13.15
Day Range
$13.07 - $13.83
Previous Close
$13.44
Last Trade
05 Nov, 4:11 pm GMT+0
Delayed
05 Nov, 4:11 pm GMT+0
STVN price performance
Delayed
05 Nov, 4:11 pm GMT+0
STVN details
STVN Market Signals